Bioactive Compounds for Anticancer Therapy
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 5740
Special Issue Editors
Interests: cancer cell line; tumors; cancer; cancer cells; xenograft studies; breast cancer; cancer biology; cancer biomarkers; cell culture; cancer diagnostics; apoptosis
Special Issues, Collections and Topics in MDPI journals
Interests: cancer cell lines; tumors; cancer; lung cancer; cancer biology; cancer biomarkers; cell culture; vitamin D; proliferation and apoptosis
Special Issue Information
Dear Colleagues,
Despite advances in medicine, cancer remains a major challenge. As a disease of the whole organism, it requires a comprehensive approach and effective therapy. Improving available anti-cancer treatments (chemotherapy and radiotherapy) with antibody-targeted therapy, vitamin supplementation, or vaccines supporting the treatment process can still be insufficient.
New molecules for targeted therapies are being sought, as well as those which, by indirectly affecting signaling pathways in the body, will prevent the development of neoplastic diseases.
This Special Issue will be dedicated to new perspectives in anticancer treatment, according to bioactive compounds of natual and synthetic origin. New uses of already known molecules/copmpunds/drugs used in other diseases, e.g., such as ionophore antibiotics or statins, also represent a somewhat important search path.
Subjects that will be discussed in this Special Issue will not only focus on new bioactive compounds, modern methods, and technologies wich can make anticancer compounds more bioawailable and more effective with less side effects, but also on the verification of its properties in animal or human studies.
Dr. Beata Filip-Psurska
Dr. Ewa Maj
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anticancer therapy
- bioactive compounds
- natural compounds
- new strategies for therapy
- nanomolecules
- old drugs new target
